comparemela.com

Latest Breaking News On - Cantargia - Page 5 : comparemela.com

Cantargia AB: Cantargia publishes preclinical data on strong anti-tumor efficacy of nadunolimab in combination with chemotherapy

LUND, Sweden, Aug. 30, 2022 /PRNewswire/ Cantargia (Cantargia AB) (Nasdaq Stockholm: CANTA) today reported publication of preclinical results demonstrating that Cantargia's lead candidate

Rydberg millrudPrnewswire cantargiaNasdaq stockholmCancer immunology

Cantargia AB: Invitation to presentation of Cantargia s report for the second quarter of 2022 on August 30 at 3 00 p m CET

Cantargia AB will publish the company's report for the second quarter for 2022 on Tuesday, August 30, 2022, at 08:30 a.m. CET. LUND, Sweden, Aug. 17, 2022 /PRNewswire/ In conjunction

United kingdomCantargia inbjudanNasdaq stockholm

Cantargia AB: Cantargia announces final outcome of the company s significantly oversubscribed rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, JAPAN, CANADA

United statesNew zealandHong kongUnited kingdomSouth africaSouth koreaAdvokatfirman vingeBaker mckenzie advokatbyrSwedish financial supervisory authorityCentral bankSwedish companies registration officeFinancial servicesCarnegie investment bankBarclays bank irelandEuropean union withdrawalCompany nasdaq stockholm

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Cantargia AB (380/22)

With effect from July 27, 2022, the subscription rights in Nasdaq will be traded on the list for Equity rights. Trading will continue up until and including August 05, 2022. Instrument: Subscription

Euroclear swedenSubs optTick sizeIssuer surveillanceNasdaq stockholm

Nasdaq Stockholm AB: Correction of Exchange notice (380/22): Listing of subscription rights and paid subscription shares of Cantargia AB (123/22)

With effect from July 27, 2022, the subscription rights in Nasdaq will be traded on the list for Equity rights. Trading will continue up until and including August 05, 2022. Instrument: Subscription

Euroclear swedenSubs optTick sizeIssuer surveillanceNasdaq stockholm

vimarsana © 2020. All Rights Reserved.